IP Library Granted Patent US 10,279,172
Granted Patent B1
US 10,279,172 · App. 15/096,089 · Granted May 7, 2019

MRI compatible lead

Inventor: Dilys Gore (Monmouthshire, GB)
A61N1/08A61N1/05A61N2001/086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,279,172
App. No.
15/096,089
Granted
May 7, 2019
Kind
B1
Abstract

A lead wire assembly apparatus for an implantable medical device (IMD), the apparatus including a lead having first and second ends and a plurality of separate conductive segments serially located therebetween; a cover defining at least one cavity situated about ends of adjacent conductive segments; and a fluid located in the at least one cavity and coupling the adjacent conductive segments to each other. The fluid electrically couples adjacent conductive segments to pass driving signals of the implantable medical device. The fluid may further attenuate induced signals generated by radiofrequency (RF) signals of a magnetic resonance (MR) system.

Claims (47)

1. A lead wire assembly apparatus for an implantable medical device (IMD), the apparatus comprising:

a lead having first and second ends and a plurality of separate conductive segments serially located therebetween;

a cover defining at least one cavity situated about ends of adjacent conductive segments; and

a fluid located in the at least one cavity, with the fluid configured to couple a signal from a first one of the adjacent conductive segments to a second one of the adjacent conductive segments.

2. The apparatus of claim 1 , wherein the fluid electrically couples adjacent conductive segments to pass driving signals of the implantable medical device.

3. The apparatus of claim 2 , wherein the fluid further attenuates induced signals generated by radiofrequency (RF) signals of a magnetic resonance (MR) system.

4. The apparatus of claim 1 , wherein the first and second ends of the lead wire define a length of the lead (LEAD) which is greater than one-half wavelength length of radiofrequency (RF) signals generated by an MRI system.

5. The apparatus of claim 4 , wherein a length of at least one of the plurality of conductive segments is less than one-half wavelength length of the radiofrequency (RF) signals generated by the MR system.

6. The apparatus of claim 1 , wherein the fluid comprises a buffer.

7. The apparatus of claim 1 , wherein the fluid comprises a conductive fluid.

8. A lead wire assembly apparatus for an implantable medical device (IMD), the apparatus comprising:

a lead having first and second ends and a plurality of separate conductive segments serially located therebetween;

a cover defining at least one cavity situated about ends of adjacent conductive segments; and

a fluid located in the at least one cavity and coupling the adjacent conductive segments to each other, wherein the fluid comprises an ionic solution.

9. A lead wire assembly apparatus for an implantable medical device (IMD), the apparatus comprising:

a lead having first and second ends and a plurality of separate conductive segments serially located therebetween;

a cover defining at least one cavity situated about ends of adjacent conductive segments; and

a fluid located in the at least one cavity and coupling the adjacent conductive segments to each other, wherein the cavity is a first cavity and ends of adjacent conductive segments are located within the first cavity coupled to corresponding conductive cylinders with a first conductive cylinder of the corresponding conductive cylinders sized to fit within a second cavity formed by a second conductive cylinder of the corresponding conductive cylinders.

10. A lead wire assembly apparatus for an implantable medical device (IMD), the apparatus comprising:

a lead having first and second ends and a plurality of separate conductive segments serially located therebetween;

a cover defining at least one cavity situated about ends of adjacent conductive segments; and

a fluid located in the at least one cavity and coupling the adjacent conductive segments to each other, wherein the lead is situated between and coupled to a signal generator and an interface probe.

11. An implantable medical device, the device comprising:

a signal generator configured to generate a driving signal;

at least one controller configured to control the signal generator to generate the driving signal;

a lead including first and second ends and a plurality of separate conductive segments serially located therebetween with the first end coupled to the signal generator, a cover defining at least one cavity, and a fluid located in the at least one cavity with the fluid configured to couple the driving signal between adjacent conductive segments; and

an interface probe coupled to the second end of the lead.

12. The device of claim 11 , wherein the fluid electrically couples adjacent conductive segments to pass the driving signal to the interface probe.

13. The device of claim 12 , wherein the fluid further attenuates induced signals generated by radiofrequency (RF) signals of a magnetic resonance (MR) system.

14. The device of claim 11 , wherein the first and second ends of the lead define a length (L LEAD ) of the lead which is greater than one-half wavelength length of radiofrequency (RF) signals generated by an MR system.

15. The device of claim 14 , wherein a length of at least one of the plurality of conductive wire segments is less than one-half wavelength length of the radiofrequency (RF) signals generated by the MR system.

16. An implantable medical device, the device comprising:

a signal generator configured to generate a driving signal;

at least one controller configured to control the signal generator to generate the driving signal;

a lead including first and second ends and a plurality of separate conductive segments serially located therebetween with the first end coupled to the signal generator, a cover defining at least one cavity, and a fluid located in the at least one cavity with the fluid electrically coupling adjacent conductive segments to each other; and

an interface probe coupled to the second end of the lead, wherein the fluid comprises a buffer.

17. An implantable medical device, the device comprising:

a signal generator configured to generate a driving signal;

at least one controller configured to control the signal generator to generate the driving signal;

a lead including first and second ends and a plurality of separate conductive segments serially located therebetween with the first end coupled to the signal generator, a cover defining at least one cavity, and a fluid located in the at least one cavity with the fluid electrically coupling adjacent conductive segments to each other; and

an interface probe coupled to the second end of the lead, wherein the fluid comprises a conductive fluid.

18. The device of claim 11 , wherein the fluid comprises an ionic solution.

19. The device of claim 11 , wherein the cavity is a first cavity and ends of adjacent conductive segments are located within the first cavity coupled to corresponding conductive cylinders with a first conductive cylinder of the corresponding conductive cylinders sized to fit within a second cavity formed by a second conductive cylinder of the corresponding conductive cylinders.

20. A method of forming a lead for attenuating signals induced by radiofrequency (RF) signals of a magnetic resonance (MR) system, the method comprising acts of:

forming a lead having first and second ends and a plurality of separate conductive segments serially located therebetween;

forming a cover defining at least one cavity in which adjacent ends of conductive segments are located; and

coupling a signal from a first one of adjacent conductive segments to a second one of the adjacent conductive segments within the at least one cavity using a fluid to perform the coupling.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: DIME COMMUNITY BANK
To: GORE, DILYS
Reel/Frame 074503/0596 →
SECURITY INTEREST Recorded Jun 17, 2019
From: DILYS GORE
To: BNB BANK
Reel/Frame 049485/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: GORE, DILYS
To: AVERY BIOMEDICAL DEVICES, INC.
Reel/Frame 038248/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: AVERY BIOMEDICAL DEVICES, INC.
To: PINNACLE BIONICS, INC.
Reel/Frame 038248/0477 →
Continuity (4)
Continuation 14924524 · Oct 27, 2015
Continuation 14660764 · Mar 17, 2015
Continuation 14481710 · Sep 9, 2014
Provisional Application 61875492 · Sep 9, 2013